Rovi Corporation (ROVI)
-NasdaqGS | Prev Close: | 24.91 |
|---|
| Open: | N/A |
|---|
| Bid: | 22.40 x 100 |
|---|
| Ask: | 25.84 x 400 |
|---|
| 1y Target Est: | 26.43 |
|---|
| Beta: | 1.58 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 9.91 - 26.55 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 848,933 |
|---|
| Market Cap: | 2.51B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.55 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Netflix does not infringe on Rovi patents - preliminary rulingReuters(Tue, 11 Jun)
- Netflix Dodges $90M Bulletsat Wall St. Cheat Sheet(Tue, 11 Jun)
- Netflix does not infringe on Rovi patents - preliminary rulingReuters(Tue, 11 Jun)
- Netflix does not infringe on Rovi patents - preliminary rulingReuters(Tue, 11 Jun)
- Netflix does not infringe on Rovi patents -preliminary rulingat Reuters(Tue, 11 Jun)
- Rovi loses in initial patent dispute reviewAP(Tue, 11 Jun)
- Rovi loses in initial patent dispute reviewAP(Tue, 11 Jun)
- Stocks Turn Lower Despite S&P Upgrade Of U.S. Outlookat Investor's Business Daily(Tue, 11 Jun)
- Netflix does not infringe Rovi patents - judge's preliminary decisionReuters(Tue, 11 Jun)
- Rovi Issues Statement in Response to Initial Determination From International Trade CommissionGlobeNewswire(Tue, 11 Jun)
Comparison
| Symbol | % Chg | Mkt Cap |
|---|
| ROVI | 0.00% | 2.51B |
| KNM.L | 0.00% | 236.31B |
| ATVI | 0.00% | 16.30B |
| 0777.HK | 1.45% | 9.65B |
| EA | 0.00% | 6.97B |
Key Statistics
| Forward P/E (1 yr): | 10.74 |
|---|
| P/S (ttm): | 3.95 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 2.10 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.46 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 1.00 |
|---|
Business Summary
Rovi Corporation provides integrated solutions that enable the discovery, delivery, display, and monetization of digital entertainment. It offers content discovery solutions, including interactive program guides; search and recommendations; cloud ...
View More